StockData
Advanced Biomed Inc. logo

Advanced Biomed Inc. (ADVB) stock

ADVBNasdaqServices-Medical LaboratoriesFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$2.53−0.78 (-23.56%)

Close on Nov 13, 2026Market cap $4.18MP/E 0.4Yield –

Advanced Biomed statistics

55 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$4.18M
$1.68B
Enterprise Value
$3.97M
$2.20B
PE Ratio
0.45
23.80
PB Ratio
0.37
3.46
P/TBV Ratio
0.37
5.80

Share statisticsIndustry

Shares Change (YoY)
33.3%
2.40%
Shares Change (QoQ)
0.00%
0.33%
Float
2M
34M
Shares Held by Insiders
0.00%
15.4%

Short sellingIndustry

Short Interest
11,238
–
Short Interest Change
15.3%
-0.86%
Short % of Float
0.68%
6.28%
Short % of Shares Outstanding
0.68%
4.21%
Days to Cover
1.00
4.41

Stock price statisticsIndustry

52-Week High
$24.23
–
52-Week Low
$1.80
–
20-Day Moving Average
$2.73
–
50-Day Moving Average
$5.11
–
200-Day Moving Average
$5.72
–
Average True Range (14)
$0.62
–
Price Change (1 Week)
27.8%
0.23%
Price Change (1 Month)
-48.2%
-0.02%
Price Change (3 Months)
-69.3%
2.13%
Price Change (6 Months)
-42.5%
17.6%
Price Change (YTD)
-56.6%
5.22%
Price Change (1 Year)
-72.0%
3.75%
Average Volume (10 Days)
121,803
–
Average Volume (20 Days)
90,788
–
Average Volume (90 Days)
1M
–
Relative Volume
0.16
0.70
Relative Strength Index (14)
39.2
46.0
Volatility (1 Year)
175.5%
64.2%

Returns on capitalIndustry

Return on Equity (ROE)
85.0%
4.82%
Return on Assets (ROA)
63.5%
-3.10%

Financial positionIndustry

Current Ratio
8.09
1.41
Quick Ratio
0.13
0.99

EfficiencyIndustry

Profits Per Employee
$506.24K
-$5.12K
Employee Count
12
910

Income statement (TTM)Industry

Pretax Income
-$6.99M
-$575.82K
Net Income
$6.07M
-$1.48M
EPS (Diluted)
$5.66
-$0.02

Balance sheetIndustry

Net Cash (Debt)
$214.00K
$203.66K
Net Cash Per Share
$0.13
$0.00
Equity (Book Value)
$11.29M
$235.60M
Book Value Per Share
$6.83
$3.91
Tangible Book Value
$11.29M
$1.59M
Working Capital
$11.28M
$30.06M

Cash flow (TTM)Industry

Operating Cash Flow
-$1.51M
$25.90M

Dividends and yieldsIndustry

Earnings Yield
145.3%
0.19%

Scores and fair valueIndustry

Graham Number
$29.50
$21.25
Graham Upside
1065.9%
-49.9%
Altman Z-Score
1.13
2.24
Piotroski F-Score
4
5

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodADVBS&P 500DifferenceADVB per yearS&P 500 per year
1 month-51.0%-3.0%−47.9 pts
3 months-70.5%-2.8%−67.7 pts
Year to date-56.6%+11.5%−68.1 pts
1 year-71.8%+13.5%−85.2 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ADVB shares were sold short on Oct 30, 2026, up 15.3% from the previous report, or 0.68% of the shares available to trade. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 55.2% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202611,238+15.3%56,3231.0
Oct 15, 20269,747-48.4%16,4121.0
Sep 30, 202618,897+91.9%22,4871.0
Sep 15, 20269,845-39.8%110,2411.0
Aug 31, 202616,357-56.2%272,5201.0
Aug 14, 202637,364-34.7%231,6121.0
Jul 31, 202657,213+441.2%8,635,8381.0
Jul 15, 202610,571-31.3%16,4341.0
Jun 30, 202615,397+73.5%14,7271.1
Jun 15, 20268,876+356.3%35,9301.0
May 29, 20261,945-47.7%43,6971.0
May 15, 20263,722-72.3%522,9251.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?